Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory.

Similar presentations


Presentation on theme: "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory."— Presentation transcript:

1 A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia  Usama Gergis, Gail Roboz, Tsiporah Shore, Ellen Ritchie, Sebastian Mayer, Usama Wissa, Marshall McKenna, Paul Christos, Roger Pearse, Tomer Mark, Joseph Scandura, Koen van Besien, Eric Feldman  Biology of Blood and Marrow Transplantation  Volume 19, Issue 7, Pages (July 2013) DOI: /j.bbmt Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 Treatment schemes for schedules A and B.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 Kaplan-Meier analyses for all patients (n = 36). (A) LFS. (B) OS. (C) LFS by day 14 blasts. (D) OS by day 14 blasts. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory."

Similar presentations


Ads by Google